HIGHLIGHTS
- who: Jing Zeng from the Xuanwu Hospital, Capital Medical University, China have published the Article: Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma, in the Journal: (JOURNAL)
- what: The study demonstrates that WHO grade 2-3 meningiomas tend to have low CD4, and CD8 expression, which has been confirmed in other studies (Fang et_al, 2013; Turner et_al, 2022). The study explored the expression of EZH2 and its relationship with H3K27me3 and the immune microenvironment in meningiomas.
- how: The authors analyzed the survival analysis of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.